Canada markets closed

Tarsus Pharmaceuticals, Inc. (TARS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.04-0.17 (-0.53%)
At close: 04:00PM EDT
32.04 0.00 (0.00%)
After hours: 05:32PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
16,154
17,447
25,816
57,027
0
Cost of Revenue
531
1,593
955
2,075
0
Gross Profit
15,623
15,854
24,861
54,952
0
Operating Expenses
Research Development
40,634
50,312
42,624
41,712
18,826
Selling General and Administrative
37,088
108,700
44,949
25,397
8,172
Total Operating Expenses
77,722
159,012
87,573
67,109
26,998
Operating Income or Loss
-62,099
-143,158
-62,712
-12,157
-26,998
Interest Expense
3,225
3,225
2,064
0
-
Total Other Income/Expenses Net
-1,071
274
-683
-1,651
-
Income Before Tax
-63,293
-135,893
-62,095
-13,772
-26,810
Income Tax Expense
50
0
-4
55
1
Income from Continuing Operations
-63,343
-135,893
-62,091
-13,827
-26,811
Net Income
-63,343
-135,893
-62,091
-13,827
-26,811
Net Income available to common shareholders
-63,336
-135,893
-62,091
-13,827
-26,811
Basic EPS
-3.84
-
-2.52
-0.67
-4.32
Diluted EPS
-3.84
-
-2.52
-0.67
-4.32
Basic Average Shares
27,726
-
24,620
20,554
6,207
Diluted Average Shares
27,726
-
24,620
20,554
6,207